Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide Ultrahaler in Persistent Asthma
NCT00174746Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2005
- Primary completion
- Nov 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ciclesonide in asthma (3 arms), sponsored by Sanofi. Primary endpoint: Forced Expiratory Volume in 1 Second at 6 weeks. Started Mar 2005; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00174746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174746.